Budesonide/cyclodextrin complex-loaded lyophilized microparticles for intranasal application

References

• Benninger MS, Anon J, Marby RL. The medical management of rhinosinustis. Otolaryngol Head Neck Surg 1997;117:S41–9
   PubMed Web of Science ®Google Scholar
• LaForce C, Raleigh NC. Use of nasal steroids in managing allergic rhinitis. J Allergy Clin Immunol 1999;103:S388–94
   Web of Science ®Google Scholar
• Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol 1995;95:1097–110
   PubMed Web of Science ®Google Scholar
• Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993;48:476–90
   PubMed Web of Science ®Google Scholar
• Onrust SV, Lamb HM. Mometasone furoate: a review of its intranasal use in allergic rhinitis. Drugs 1998;56:725–45
   PubMed Web of Science ®Google Scholar
• Szefler SJ. Pharmacokinetics of intranasal corticosteroids. J Allergy Clin Immunol 2001;108:S26–31
   PubMed Web of Science ®Google Scholar
• Malo JL, Cartier A, Ghezzo H, et al. Skin brushing, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone. Eur J Respir 1999;13:993–8
   PubMed Web of Science ®Google Scholar
• Pedersen S, ÓByrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52:1–34
   PubMed Web of Science ®Google Scholar
• Szefler SJ. Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid. J Allergy Clin Immunol 1999;104:175–83
   PubMed Web of Science ®Google Scholar
• Stanley JS, Denver C. Pharmacokinetics of intranasal corticosteroids. J Allergy Clin Immunol 2001;108:S26–31
   PubMed Web of Science ®Google Scholar
• Bandi N, Wei W, Roberts CB, et al. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single step, organic-solvent-free supercritical fluid process. Eur J Pharm Sci 2004;23:159–68
   PubMed Web of Science ®Google Scholar
• Joshi MR, Misra A. Liposomal budesonide for dry powder inhaler: preparation and stabilization. AAPS PharmSciTech 2001;2:25–31
   PubMedGoogle Scholar
• Parmar JJ, Singh DJ, Hedge DD, et al. Development and evaluation of inhalational liposomal system of budesonide for better management of asthma. Indian J Pharm Sci 2010;72:442–8
   PubMed Web of Science ®Google Scholar
• Buttini F, Colombo P, Wenger MP, et al. Back to basics: the development of a simple, homogenous, two-component dry-powder inhaler formulation for the delivery of budesonide using miscible vinyl polymers. J Pharm Sci 2008;97:1257–67
   PubMed Web of Science ®Google Scholar
• Mezzena M, Scalia S, Young PM, Traini D. Solid lipid budesonide microparticles for controlled release inhalation therapy. AAPS J 2009;11:771–8
   PubMed Web of Science ®Google Scholar
• El-Gendy N, Gorman EM, Monson EJ, Berkland C. Budesonide agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci 2009;98:2731–46
   PubMed Web of Science ®Google Scholar
• Surti N, Misra A. Wheat germ agglutinin-conjugated nanoparticles for sustained cellular and lung delivery of budesonide. Drug Deliv 2008;15:81–6
   PubMed Web of Science ®Google Scholar
• Lenhardt T, Vergnault G, Grenier P, et al. Evaluation of nanosuspensions for absorption enhancement of poorly soluble drugs: in vitro transport studies across intestinal epithelial monolayers. AAPS J 2008;10:435–8
   PubMed Web of Science ®Google Scholar
• Yang JZ, Young AL, Chiang PC, et al. Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization and pharmacokinetic studies. J Pharm Sci 2008;97:4869–78
   PubMed Web of Science ®Google Scholar
• Amani A, York P, Chrystyn H, Clark BJ. Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers. AAPS PharmSciTech 2010;11:1147–51
   PubMed Web of Science ®Google Scholar
• Liu H, Zhou LL, Wei LL, et al. Preparation of budesonide-poly(ethylene oxide) solid dispersions using supercritical fluid technology. Drug Dev Ind Pharm 2007;33:959–66
   PubMed Web of Science ®Google Scholar
• Toropainen T, Velaga S, Heikkilä T, et al. Preparation of budesonide/gamma-cyclodextrin complexes in supercritical fluids with a novel SEDS method. J Pharm Sci 2006;95:2235–45
   PubMed Web of Science ®Google Scholar
• Ozdemir N, Erkin J. Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin. Drug Dev Ind Pharm 2012;38:331–40
   PubMed Web of Science ®Google Scholar
• Jug M, Maestrelli F, Bragagni M, Mura P. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. J Pharm Biomed Anal 2010;52:9–18
   PubMed Web of Science ®Google Scholar
• Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1–11
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Yoo BK, Woo JS, et al. Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with beta-cyclodextrin. Arch Pharm Res 2007;2:249–54
   Google Scholar
• Cho HJ, Balakrishnan P, Shim WS, et al. Characterization and in vitro evaluation of freeze-dried microparticles composed of granisetron-cyclodextrin complex and carboxymethylcellulose for intranasal delivery. Int J Pharm 2010;400:59–65
   PubMed Web of Science ®Google Scholar
• Loftsson T, Vogensen SB, Brewster ME, Konrádsdóttir F. Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci 2007;96:2532–46
   PubMed Web of Science ®Google Scholar
• Cho HJ, Balakrishnan P, Chung SJ, et al. Evaluation of protein stability and in vitro permeation of lyophilized polysaccharides-based microparticles for intranasal protein delivery. Int J Pharm 2011;416:77–84
   PubMed Web of Science ®Google Scholar
• Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release 2007;123:78–99
   PubMed Web of Science ®Google Scholar
• Dyvik K, Graffner C. Investigation of the applicability of a tensile testing machine for measuring mucoadhesive strength. Acta Pharm Nord 1992;4:79–84
   PubMedGoogle Scholar
• Henriksen I, Green KL, Smart JD, et al. Bioadhesion hydrated chitosans: an in vitro and in vivo study. Int J Pharm 1996;145:231–40
   Web of Science ®Google Scholar
• Burdock GA. Safety assessment of hydroxypropyl methylcellulose as a food ingredient. Food Chem Toxicol 2007;45:2341–51
   PubMed Web of Science ®Google Scholar
• Ugwoke MI, Agu RU, Vanbilloen H, et al. Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p((R)) and carboxymethylcellulose. J Control Release 2000;68:207–14
   PubMed Web of Science ®Google Scholar
• Ugwoke MI, Agu RU, Jorissen M, et al. Toxicological investigations of the effects carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa. Int J Pharm 2000;205:43–51
   PubMed Web of Science ®Google Scholar
• Higuchi T, Connors K. Phase solubility techniques. Adv Anal Chem Instrum 1965;7:117–212
   Google Scholar
• Cho HJ, Balakrishnan P, Lin H, et al. Application of biopharmaceutics classification system (BCS) in drug transport studies across human respiratory epithelial cell monolayers. J Pharm Invest 2012;42:147–53
   Google Scholar
• Lee MK, Yoo JW, Lin H, et al. Serially passaged human nasal epithelial cell monolayer for drug transport studies: comparison between liquid-cover condition (LCC) and air-liquid interface (ALI) culture condition. Drug Deliv 2005;12:305–11
   PubMed Web of Science ®Google Scholar
• Merkus FWHM, Verhoef JC, Marttin E, et al. Cyclodextrins in nasal drug delivery. Adv Drug Deliv Rev 1999;36:41–57
   PubMed Web of Science ®Google Scholar
• Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 2001;53:3–21
   PubMed Web of Science ®Google Scholar
• Wang Z, Deng Y, Sun S, Zhang X. Preparation of hydrophobic drugs cyclodextrin complex by lyophilization monophase solution. Drug Dev Ind Pharm 2006;32:73–83
   PubMed Web of Science ®Google Scholar
• Martin TA, Bandi N, Schulz R, et al. Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology. AAPS PharmSciTech 2002;3:16–26
   Google Scholar
• Chowdary KP, Srinivas SV. Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl-beta-cyclodextrin. AAPS PharmSciTech 2006;7:E184–9
   PubMed Web of Science ®Google Scholar
• Cirri M, Righi MF, Maestrelli F, et al. Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers. Drug Dev Ind Pharm 2009;35:73–82
   PubMed Web of Science ®Google Scholar
• Singh SK, Srinivasan KK, Singare DS, et al. Formulation of ternary complexes of glyburide with hydroxypropyl-β-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds. Drug Dev Ind Pharm 2012;38:1328–36
   PubMed Web of Science ®Google Scholar
• Borghetti GS, Pinto AP, Lula IS, et al. Daidzein/cyclodextrin/hydrophilic polymer ternary systems. Drug Dev Ind Pharm 2011;37:886–93
   PubMed Web of Science ®Google Scholar